Results 1 to 10 of about 2,529,459 (356)

Protocol for assessing T cell receptor-mediated human T cell cytotoxicity [PDF]

open access: yesSTAR Protocols
Summary: Measuring the cytotoxicity of human T cells is a valuable but challenging task. We present a protocol for assessing the ability of polyclonal human T cells to kill target cells upon T cell receptor (TCR) triggering.
Kathryne E. Marks   +3 more
doaj   +2 more sources

TRain: T-cell receptor automated immunoinformatics [PDF]

open access: yesBMC Bioinformatics
Background The scarcity of available structural data makes characterizing the binding of T-cell receptors (TCRs) to peptide-Major Histocompatibility Complexes (pMHCs) very challenging.
Austin Seamann   +5 more
doaj   +2 more sources

The T cell receptor sequence influences the likelihood of T cell memory formation [PDF]

open access: yesCell Reports
Summary: The amino acid sequence of the T cell receptor (TCR) varies between T cells of an individual’s immune system. Particular TCR residues nearly guarantee mucosal-associated invariant T (MAIT) and natural killer T (NKT) cell transcriptional fates ...
Kaitlyn A. Lagattuta   +7 more
doaj   +2 more sources

Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen [PDF]

open access: yesNature Communications
T cell receptor-engineered T cells (TCR-T) could be advantageous in glioblastoma by allowing safe and ubiquitous targeting of the glioblastoma-derived peptidome.
Yu-Chan Chih   +28 more
doaj   +2 more sources

T-cell receptor and B-cell receptor repertoires profiling in pleural tuberculosis [PDF]

open access: yesFrontiers in Immunology
BackgroundTuberculosis (TB) is a leading cause of death worldwide from a single infectious agent. In China the most common extra-pulmonary TB (EPTB) is pleural tuberculosis (PLTB).
Fengjiao Du   +12 more
doaj   +2 more sources

T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies

open access: yesNature Communications, 2022
Healthy T cells are polyclonal, while malignant T cells are developing via clonal expansion. Here authors show that T cell tumours could be eradicated by chimeric antigen receptor T cells targeting the T cell receptor (TCR) β-chain that is specific to ...
Fanlin Li   +17 more
doaj   +1 more source

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies

open access: yesFrontiers in Immunology, 2021
Transcription factor and oncosuppressor protein p53 is considered as one of the most promising molecular targets that remains a high-hanging fruit in cancer therapy.
Vitaly Chasov   +9 more
doaj   +1 more source

The Chemokine Receptor CCR5 Links Memory CD4+ T Cell Metabolism to T Cell Antigen Receptor Nanoclustering

open access: yesFrontiers in Immunology, 2021
The inhibition of anabolic pathways, such as aerobic glycolysis, is a metabolic cornerstone of memory T cell differentiation and function. However, the signals that hamper these anabolic pathways are not completely known.
Raquel Blanco   +8 more
doaj   +1 more source

Novel clonality assays for T cell lymphoma in cats targeting the T cell receptor beta, T cell receptor delta, and T cell receptor gamma loci

open access: yesJournal of Veterinary Internal Medicine, 2021
Background T cell clonality assays in veterinary medicine currently target only the T cell receptor gamma (TRG) locus. Existing assays have suboptimal sensitivity because of insufficient primer coverage of all possible rearrangements.
Araya Radtanakatikanon   +3 more
doaj   +1 more source

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer

open access: yesTurkish Journal of Hematology, 2023
Antigen-specific retargeting of cytotoxic lymphocytes against tumorassociated antigens has thus far remained largely dependent on chimeric antigen receptors (CARs) that can be constructed by the fusion of an extracellular targeting domain (classically a ...
Zeynep Sena Karahan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy